tradingkey.logo
tradingkey.logo
Buscar

Intelligent Bio Solutions Inc

INBS
Añadir a la lista de seguimiento
2.240USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
4.48MCap. mercado
PérdidaP/E TTM

Más Datos de Intelligent Bio Solutions Inc Compañía

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Información de Intelligent Bio Solutions Inc

Símbolo de cotizaciónINBS
Nombre de la empresaIntelligent Bio Solutions Inc
Fecha de salida a bolsaDec 23, 2020
Director ejecutivoSimeonidis (Harry)
Número de empleados16
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 23
Dirección135 W 41St St,
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10036
Teléfono16467905756
Sitio Webhttps://ibs.inc/
Símbolo de cotizaciónINBS
Fecha de salida a bolsaDec 23, 2020
Director ejecutivoSimeonidis (Harry)

Ejecutivos de Intelligent Bio Solutions Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
34.54K
+88.30%
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
5.01K
+99.88%
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
5.00K
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
5.00K
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Intelligent Bio Solutions Inc?

Los cinco principales accionistas de Intelligent Bio Solutions Inc son: Mr. Harry Simeonidis

¿Cuántas instituciones poseen acciones de Intelligent Bio Solutions Inc (INBS)?

A fecha de 2026Q1, 29 instituciones poseen acciones de Intelligent Bio Solutions Inc, con un valor de mercado combinado de aproximadamente 1.95K, lo que representa el 0.09% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -189189.00.